Related Experiment Video
Updated: Feb 16, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways
Wenzhi Shen1, Renle Du1, Jun Li1
1Department of Immunology, School of Medicine, Nankai University, Tianjin, China.
Abstract:
TIFA, also called T2BP, was first identified using yeast two-hybrid screening. Our previous work showed that TIFA suppresses hepatocellular carcinoma (HCC) progression via apoptosis and cell cycle arrest. However, the mechanism by which this TIFA suppression occurs remains unclear. Here we demonstrated that TIFA-induced apoptosis demonstrates two distinct time patterns (i.e., at 48 h and >7 days) when TIFA reconstitution occurs. Moreover, we found that MALT1 (a competitor of TIFA) plays a crucial role in short-duration TIFA reconstitution. In this regard, MALT1 silencing with shRNA markedly enhances TIFA-induced apoptosis in vitro and in vivo. In addition, TIFA overexpression triggers JNK and p38 activation in long-duration TIFA reconstitution through TRAF6 binding. In particular, JNK activation leads to TIFA-induced apoptosis while p38 activation governs TIFA-induced cell cycle arrest by p53-p21 signaling in vitro and in vivo. Our data suggest a novel mechanism by which TIFA suppresses HCC progression via both MALT1-dependent and MALT1-independent signaling pathways. This may provide insights into a novel targets where HCC progression may be vulnerable to clinical treatment.
Insights
TIFA protein suppresses hepatocellular carcinoma (HCC) progression. Its mechanism involves distinct apoptosis patterns and signaling pathways, including MALT1, JNK, and p38, offering new therapeutic targets for HCC.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- TIFA (T2BP) was previously shown to suppress hepatocellular carcinoma (HCC) progression.
- The precise molecular mechanisms underlying TIFA's tumor-suppressive functions remain largely unelucidated.
Purpose of the Study:
- To elucidate the detailed molecular mechanisms by which TIFA suppresses HCC progression.
- To investigate the distinct temporal patterns and signaling pathways involved in TIFA-mediated apoptosis and cell cycle arrest.
Main Methods:
- Yeast two-hybrid screening for TIFA identification.
- RNA interference (shRNA) for MALT1 silencing.
- Overexpression studies for TIFA.
- Western blotting and signaling pathway analysis (JNK, p38, TRAF6, p53-p21).
- In vitro and in vivo experimental models.
Main Results:
- TIFA-induced apoptosis exhibits two distinct time patterns (48 hours and >7 days).
- MALT1 acts as a competitor to TIFA; MALT1 silencing enhances TIFA-induced apoptosis.
- TIFA overexpression activates JNK (apoptosis) and p38 (cell cycle arrest via p53-p21) in a TRAF6-dependent manner.
- Both MALT1-dependent and independent pathways mediate TIFA's tumor-suppressive effects.
Conclusions:
- TIFA suppresses HCC progression through complex, time-dependent signaling pathways.
- MALT1 plays a critical role in short-term TIFA activity, while TRAF6-mediated JNK/p38 activation is key for long-term effects.
- Understanding these pathways reveals potential novel therapeutic targets for HCC treatment.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
Abnormal Proliferation